Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Study introduces Reverse Vaccine Development as a strategic approach to identify correlates of protection early in vaccine development against antimicrobial-resistant pathogens, aiming to mitigate risks such as significant phase-III clinical trial failures.

Related Keywords

Kateryna Kon ,Vaccine Development ,Npj Vaccines ,Reverse Vaccine Development ,Antimicrobial Resistance ,Vaccine ,Ntibody ,Clinical Trial ,Coronavirus ,Efficacy ,Shiv ,Mmunodeficiency ,Malaria ,Athogen ,Public Health ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Virus ,